Efficacy and Safety of Ramelteon in the Reduction of Delirium and Duration of ICU Stay: A Randomized Placebo-Controlled Trial.

Cureus · 2025 · PMC12415405 · PMID 40926919

Europe PMC DOI

hedged sentence

0.1625

closest p · 3.3× alpha

0.1625

boldest claim

The sentences

did not reach statistical significancep = 0.1625not close (p > 0.1)

Although the incidence of delirium was lower in the ramelteon group (7/27, 25.93%) compared to the placebo group (13/28, 46.43%), this difference did not reach statistical significance (p = 0.1625).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.